Icad stocktwits
![icad stocktwits icad stocktwits](https://i.redd.it/k8670be7jrg71.png)
This figure implies a 63% one-year upside. Unsurprisingly, Brisebois rates ICAD an Outperform (i.e. Ultimately, while ProFound AI Risk is in its very early stages of launch, we believe it represents a great example of AI’s potential in changing treatment paradigms,” Brisebois opined.
![icad stocktwits icad stocktwits](https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?w=250&h=150&zc=2&src=https://www.marketbeat.com/logos/icad-inc-logo.png)
We believe ICAD represents an attractive vehicle for investors looking for exposure to biotech innovation themes and AI data growth waves. “We believe growth investors will be rewarded over the years as ICAD gains further share in a growing TAM by providing transformative AI-driven breast cancer detection products as well as targeted, efficient, cancer therapy solutions (quality over quantity). Year-over-year, quarterly revenue was up 11%, and the ProFound AI sales, in particular, gained 21%.Ĭovering this stock for Oppenheimer, analyst Francois Brisebois sees ProFound AI as powerful gainer for the company. The field, like much of the medical industry, is growth, and iCAD reported $10.5 million in revenues for 4Q20, a sequential gain of 47%, which was powered by a 70% sequential gain in product revenue from ProFound AI. It’s part of a natural trend in medtech, of greater integration of tools and treatments. Medical technology is in high demand, and iCAD’s AI-powered platforms take common diagnostic tools and improve their accuracy. The company’s ProFound AI Risk tool is an integrated platform that streamlines the diagnosis and treatment of breast cancer the VeraLook platform uses similar advanced technology to improve image processing in the detection of colon polyps. iCAD offers a comprehensive platform of hardware and software. We’ll start in the medtech segment, where iCAD produces solutions, including advanced image analysis, radiation therapy, and workflow to facilitate early identification and treatments for cancer. With this in mind, we’ve opened up the TipRanks database to get the scoop on three “Strong Buy” stocks, according to the analyst community, which are making profitable use of AI technology, and jockeying for position out of the gate. AI is here, and it’s only going to expand its presence. New AI systems are making possible autonomous vehicles, personalizing sales and marketing, and speeding up the networked systems that hold the digital universe together.įrom an investor standpoint, the companies that are building and using AI systems now are in position for gains in the near future. AI systems, which allow machines to learn from experience, adapt to change, and process more information faster than ever before, are powering the evolution of tech. Tech companies, whether large or small, are clearly in a position to gain from this trend, offering the products and innovations that will facilitate and expand the growth of our high-tech footprint.Īrtificial Intelligence, or AI, is at the forefront the tech wave. It’s understandable our digital world has clearly passed a point of no return in the integration of tech with our daily lives. Hi tech is the cool kid of investment sectors, offering an unbeatable combination of cutting edge chic and long-term stock market returns.